Prdm16 Amplifies Notch Signaling and Suppresses Venous Lineage Specification to Prevent Arteriovenous Malformations During Vascular Development
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.125.323552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Jore Van Wauwe und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Belgium (J.V.W., S.C., P.V., H.K., M.D., A.L.). Hauptthemen laut MEDLINE: Receptors, Notch, Zebrafish Proteins, Transcription Factors, DNA-Binding Proteins. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: TF (transcription factor) Prdm16 (positive regulatory domain–containing protein 16) regulates hematopoietic and neuronal stem cell homeostasis, adipose differentiation, and cardiac development. Its role in the circulatory system extends beyond the heart, as Prdm16 loss in arterial endothelial cells (ECs) impairs arterial reperfusion of ischemic mouse limbs due to endothelial dysfunction, and PRDM16 polymorphisms are associated with coronary artery disease. METHODS: Zebrafish were used to analyze vascular development, arteriovenous endothelial specification, and the emergence of arteriovenous malformations in the absence or presence of Prdm16 or Notch signaling. Lentiviral-mediated Prdm16 overexpression in human endothelial (progenitor) cells was coupled to qRT-PCR, Western blot, and transcriptional profiling to document Prdm16’s importance for arterial lineage specification. Coimmunoprecipitation in HEK293 (human embryonic kidney 293) cells was performed to assess physical interaction between Prdm16 and the Notch pathway. Existing mouse and human data sets were reanalyzed to evaluate Prdm16 expression in mammalian arteriovenous malformations. RESULTS: Prdm16 actively promotes arterial EC identity while suppressing venous fate. Like in mice, Prdm16 is expressed by arterial ECs early during vascular development in zebrafish, where it synergistically coordinates arterial development together with canonical notch signaling, as their combined loss in zebrafish leads to arteriovenous malformations. PRDM16’s arterializing effect on human ECs is dependent on canonical Notch activity, as it is blunted in the presence of canonical Notch inhibitors and potentiated in the presence of delta-like ligand 4. Mechanistically, Prdm16 does not increase the protein levels of the cleaved intracellular domain of Notch receptors (notch intracellular domain) but rather potentiates the effect of the latter via physical and functional interaction. Prdm16 further finetunes Notch signaling and arterial development by complexing with Hey2 (Hes-related family bHLH TF with YRPW motif 2), the basic helix-loop-helix TF acting downstream of canonical Notch during arterial lineage specification and development. CONCLUSIONS: Together, our data demonstrate an intricate interplay between Prdm16 and Notch in ECs and indicate that Prdm16 signaling may constitute a novel therapeutic target for arteriovenous malformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Belgium (J.V.W., S.C., P.V., H.K., M.D., A.L.).
- Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Germany (P.J., T.R., M.F., M.B.).
- German Centre of Cardiovascular Research (DZHK), Partner Site Hamburg-Luebeck-Kiel, Hamburg (P.J., D.P., M.F., M.B.).
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.K., L.A., C.F., S.W., C.A.M., M.B.).
- Department of Biomedical Engineering, Boston University, MA (S.W.).
- Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (C.M.).
ORCID-Profile: Jore Van Wauwe, Ashmita Kc, Pieter Vrancaert, Hannelore Kemps, Christopher Finck, Christian Müller, Nicholas D Leigh, Thomas Renné, Roxana Ola, Maike Frye, Calum A MacRae, Aernout Luttun, Manu Beerens
Zitieren
APA
Van Wauwe, J., Janarthanan, P., Craps, S., Kc, A., Asuncion, L., Vrancaert, P., Kemps, H., Daems, M., Finck, C., Wright, S., Müller, C., Leigh, N. D., Renné, T., Ola, R., Panáková, D., Frye, M., MacRae, C. A., Luttun, A., & Beerens, M. (2026). Prdm16 Amplifies Notch Signaling and Suppresses Venous Lineage Specification to Prevent Arteriovenous Malformations During Vascular Development. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323552
Vancouver
Van Wauwe J, Janarthanan P, Craps S, Kc A, Asuncion L, Vrancaert P, et al. Prdm16 Amplifies Notch Signaling and Suppresses Venous Lineage Specification to Prevent Arteriovenous Malformations During Vascular Development. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323552
BibTeX
@article{VanWauwe2026,
author = {Van Wauwe, Jore and Janarthanan, Pavithra and Craps, Sander and Kc, Ashmita and Asuncion, Lisabel and Vrancaert, Pieter and Kemps, Hannelore and Daems, Margo and Finck, Christopher and Wright, Shane and Müller, Christian and Leigh, Nicholas D and Renné, Thomas and Ola, Roxana and Panáková, Daniela and Frye, Maike and MacRae, Calum A and Luttun, Aernout and Beerens, Manu},
title = {Prdm16 Amplifies Notch Signaling and Suppresses Venous Lineage Specification to Prevent Arteriovenous Malformations During Vascular Development},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.125.323552}
}
EUVIMED